Introduction
Epithelial-mesenchymal transition (EMT) is a biologic process that allows a polarized epithelial cell, which normally interacts with the basement membrane via its basal surface, to undergo multiple biochemical changes that enable the epithelial cell to assume a mesenchymal cell phenotype. This, in turn, provides the cell with enhanced migratory capacity, invasiveness, and increased resistance to apoptosis (1) . The completion of an EMT is signaled by the degradation of the underlying basement membrane and the formation of a mesenchymal cell that can migrate away from the epithelial layer from which it originated.
In EMT, epithelial cells acquire fibroblast-like properties and show reduced intercellular adhesion and increased motility. This process is associated with the functional loss of E-cadherin (2, 3) . In cancer, down-regulation of E-cadherin is the key step towards the invasive phase of carcinoma, and dominant transcriptional repression is largely responsible for the loss of E-cadherin expression (4) (5) (6) (7) (8) .
The conversion of an epithelial cell into a mesenchymal cell requires alterations in morphology, cellular architecture, adhesion, and migration capacity. Increased expression of N-cadherin and vimentin, nuclear localization of β-catenin, and increased production of transcription factors such as Snail1 (Snail), Snail2 (Slug), Twist, EF1/ZEB1, SIP1/ZEB2, and/or E47 that inhibit E-cadherin production are the commonly used molecular markers for EMT. Phenotypic markers of EMT include an increased capacity for migration and three-dimensional invasion, as well as resistance to anoikis/ apoptosis (9) . Importantly, these developmental regulators can induce EMT in a non-developmental context and thereby have an important role in cancer and fibrosis.
The MET receptor tyrosine kinase was one of the first www.bjournal.com.br Braz J Med Biol Res 44(7) 2011 identified cell surface receptors that was able to stimulate scattering of epithelial cells. Activation of MET by its ligand, hepatocyte growth factor, enhances the migration of multiple cell lines in vitro. The RON protein is a typical receptor tyrosine kinase (RTK) belonging to the MET family (10, 11) . Induction of RON phosphorylation and kinase activities can be achieved through ligand-dependent and -independent mechanisms (12) . Binding of macrophage stimulating protein (MSP) to extracellular sequences of RON leads to receptor homo-dimerization, which is a typical example of ligand-induced RON activation (13, 14) . Ligandindependent RON activation was observed in various physiological and pathological conditions (15) (16) (17) . Aberrant RON expression also results in receptor phosphorylation and kinase activation (16) (17) (18) , which contributes to the pathogenesis and malignancy of epithelial tumors. The present investigation was undertaken to determine the role and the mechanisms of RON in EMT in MadinDarby canine kidney (MDCK) cells. Currently, the details of mechanisms underlying RON-mediated cell migration and shape change are unknown. Through a series of experiments, we demonstrated that RON could mediate EMT in MDCK cells through the Erk1/2 pathway. Thus, RON may be involved in tumor progression and metastasis.
Material and Methods

Cell lines and reagents
The MDCK cells derived from a kidney of an apparently normal adult female cocker spaniel were obtained from the American Type Culture Collection (ATCC, USA). RE7 cells, stably expressing RON as described previously (14) , were derived from MDCK cells transfected with wt-RON. The rabbit anti-RON antibody (R5029) was a gift from Prof. Wang (Center for Biology Therapeutics, School of Pharmacy, Texas Tech University Health Sciences Center, USA). MSP was obtained from R&D System (USA). PD98059 as an Erk1/2 inhibitor was purchased from Cell Signaling Technology (USA). Goat or rabbit IgG antibodies specific for Pan-Erk, phosphor-Erk1/2 (p44/42), E-cadherin, vimentin, Snail, Twist, regular or phosphor glycogen synthase kinase-3β (GSK-3β) and AKT were purchased from Cell Signaling Technology (USA) and Santa Cruz Biotechnology (USA), respectively. Rabbit IgG antibodies (R5029) specific for human RON C-terminal peptides were used as previously described (19) .
Cell lysates
All cells were lysed using cell lysis buffer (10X) containing 20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 1 mM Na 2 EDTA, 1 mM EGTA, 1% Triton, 2.5 mM sodium pyrophosphate, 1 mM beta-glycerophosphate, 1 mM Na 3 VO 4 , and 1 μg/mL leupeptin (Cell Signaling Technology). Samples containing 1 x 10 6 cells were lysed in 200 μL cell lysis buffer (1X) for 30 min at 4°C. The insoluble material was then removed by centrifugation at 8000 g for 10 min. The concentration of protein in each lysate was determined using a BCA protein assay kit (Pierce, USA) with bovine serum albumin as the standard.
Western blot analysis
Western blot was carried out using specific antibodies followed by goat anti-rabbit, or mouse IgG coupled with HRP (Santa Cruz). The reaction was developed with enhanced ECL reagents and analyzed with a VersaDoc Imaging system (Bio-Rad).
Cell migration assays
MDCK and RE7 cells were cultured in Dulbecco's modified Eagle's medium (DMEM) containing 10% fetal bovine serum at 37°C in a humidified atmosphere containing 5% CO 2 . When the cells reached 60-70% confluence in a 60-mm dish they were cultured in serum-free DMEM for 24 h. The cell monolayers were scored with a 200-μL plastic tip and then treated with 2 nM MSP and/ or 50 μM PD98059. Cell migration into the wounded area was measured after 24 h. During the migration assay, the cells were taken out of the incubator and placed under a Olympus 1 x 2-UCB microscope with a 100X objective. Pictures of fixed positions in the wounds were taken with a Q IMAGING Micropublisher 5.0 RTV that was mounted on the microscope. Subsequently, the wound area in each picture was determined by outlining the wound and measuring the area using the Image-Pro Plus 6.0 software. From the wound area, the average wound width could be obtained by dividing the area by the length of the region analyzed.
Results
Increased morphological changes and cell migration in MSP-stimulated RE7 cells RON activation mediates various activities including cell shape change and migration. We tested the morphogenic effect of RON on RE7 cells. MDCK and RE7 cells (1 x 10 4 cells per well in a 6-well plate) were stimulated with 2 nM MSP for 72 h. The changes in cell morphology were recorded with a light microscope (Figure 1) . The results showed that, upon stimulating cells with MSP for 72 h, scatter-like activities were observed as judged by cell-cell dissociation in RE7 cells. Individual cell morphology was also altered dramatically, with elongated shapes and a rounded appearance. The appearance of scatter-like activities suggests that RON acts as a morphogenic factor for cells.
The effect of RON on cell migration was also determined in a wound-healing assay. Stimulation of cells with MSP resulted in increased RE7 cell migration (about 69% of the wounded areas were covered) (Figure 2) . Thus, RON induced morphological changes and cell migration in RE7 cells. 
The changes of signaling molecules in MSP-stimulated RE7 cells
MSP-induced RON activation resulted in the increased activation of Erk1/2 and inactivation of GSK-3β in RE7 cells compared with MDCK cells (the percent of the activation and inactivation ratio was Erk1 = 143.6%, Erk2 = 599.8%, and GSK-3β = 512.4%), but the activation of AKT and IκBα was not changed (Figure 4 ). The expression of Snail in 2 nM MSP-stimulated RE7 cells increased over time (from 0, 15, 30 min, 1, 2, and 6 h; Figure 5 ), while the relative density ratio of Snail and β-actin increased from 0.428 to 1.333. These results demonstrate that MSP-induced RON activation is capable of activating downstream signaling pathways such as Erk1/2 in RE7 cells.
Inhibitory effect of PD98059 on MSP-stimulated RE7 cells
To determine which signaling pathways are involved in enhanced cell migration and shape change, RE7 cells were stimulated with MSP in the presence of specific chemical inhibitors such as PD98059 (for Erk1/2), which is specific to MAPK/ERK kinase. PD98059 (50 μM) inhibited MSPinduced activation of Erk1/2 (p44/42; Figure 6 ). The expression of phosphorylated GSK-3β, Snail, and vimentin was decreased over time (from 0 to 15 and 30 min, and after 1, 2, and 6 h). No change in cell signaling molecules was seen in cells treated with Wortmannin (data not shown).
In a wound-healing assay, stimulation of cells with MSP resulted in increased RE7 cell migration (Figure 2 ). PD98059 showed inhibitory effects on RE7 cell migration, inhibiting not only spontaneous migration, but also MSPinduced cell motility (about 25-28% of wounded areas were covered, respectively).
Discussion
We determined the role and the mechanisms of RON in EMT. RON activation transduces multiple signals that control cell replication, scattering, migration, and invasion of extracellular matrices (12) . RON is involved in the EMT of MDCK cells. RON expression promotes transformation of cells from an epithelial phenotype to a mesenchymal phenotype. As shown in Figures 1 and 2 , scatter-like activities with elongated shapes and a rounded appearance were observed in RE7 cells expressing RON, but not in normal MDCK cells. The phenotype of RE7 cells was different from that of MDCK cells, as shown by the absence of E-cadherin, the presence of vimentin, and up-regulation of Snail in RE7 cells relative to MDCK cells. Moreover, MSP stimulation induced cell migration (Figure 2) , which suggests that activated RON transduces signals that activate the motile machinery of the cell, possibly playing a role in promoting invasive activity in vivo.
Our results also demonstrated that constitutive expression of RON in MDCK cells resulted in alterations of cell morphology with increased motile-invasive activities. These changes were characterized by the loss of epithelial markers such as adherent protein E-cadherin and the gain of mesenchymal phenotypes including the increased expression of vimentin.
The morphological changes mediated by RON are manifested through various signaling pathways such as Erk1/2 and AKT, thus altering cell adhesion, reorganizing the cytoskeleton, and reducing cellular interaction (12, 19) . The expression of RON was accompanied by tyrosine phosphorylation, which indicated constitutive activation. MSP further regulated RON phosphorylation, leading to the activation of downstream signaling proteins such as Erk1/2 and GSK-3β (Figure 4) . The results indicated that the activation of Erk1/2 stimulated with RON can lead to the increased expression of p-GSK-3β, in agreement with previous results (20, 21) . It has been reported that MAPK can inactivate GSK-3β by direct phosphorylation at its C terminus (21) . Thus, the up-regulation of p-GSK-3β induced down-regulation of GSK-3β activation.
MSP-induced RON activation also enhanced the expression of Snail in a time-dependent manner ( Figure 5 ), which was regulated by GSK-3β. Snail was first identified in Drosophila, where it down-regulates the transcription of shotgun (an E-cadherin orthologue) to control gastrulation (3). Snail homologues have subsequently been found in many other species, including humans (3). Recently, Snail was shown to repress the expression of E-cadherin and to induce EMT in MDCK cells (22) (23) (24) , which indicated that Snail has a fundamental role in EMT through its suppression of E-cadherin. Snail is a GSK-3β substrate, while inhibition of GSK-3β results in the up-regulation of Snail and down-regulation of E-cadherin in vivo (20) .
Inhibition of MAP kinase activities by the specific chemical inhibitor PD98059 completely blocked cell migration. MSP-induced activation of Erk1/2 (p44/42) was inhibited by PD98059 ( Figure 6 ). The expression of phosphorylated GSK-3β, Snail, and vimentin was decreased over time. RE7 cell migration stimulated with MSP could also be inhibited by PD98059. Thus, the down-regulated expression of Snail inhibited by PD98059 indicated that it could function as a promoter for EMT, which was induced with Erk1/2 and reinforced the notion that cell migration and cancer metastasis are finely tuned events.
At present, the precise signaling pathways that transduce RON signals leading to EMT are largely unknown (19) . However, the results shown here in Figures 4 and 6 provide important clues indicating that the activation of MAPK/Erk pathways might be critical. As shown in Figure  4 , RON activation led to increased activation of Erk1/2, the constitutive components of the MAPK pathway. Blocking Erk1/2 activation by PD98059 might prevent the MSPinduced EMT with the decreased expression of vimentin. The regulation of Snail by GSK-3β reveals that many oncogenic pathways could govern human cancer cell invasion and metastasis by modulating GSK-3β activity. GSK-3β is a multi-tasking kinase involved in the Akt, Wnt, and Hedgehog pathways, all of which are engaged in the determination of cell fate and morphology (25) . GSK-3β has been reported to bind and phosphorylate Snail and thereby induce its nuclear export (20) . Therefore, the Erk1/2 oncogenic signals stimulated with RON inhibited GSK-3β and thus in turn resulted in the stabilization and nuclear localization of Snail to trigger cell migration and EMT. Since Snail regulates E-cadherin (26), we speculate that the down-regulation of GSK-3β by this pathway promoted and stabilized Snail and inhibited E-cadherin, to induce cell migration and lead to EMT.
Thus, our results indicate that RON could mediate EMT in MDCK cells. This occurred through the Erk1/2 pathway, which inhibited GSK-3β, and in turn resulted in the stabilization of Snail and the down-regulation of E-cadherin.
